- Trials with a EudraCT protocol (1,654)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (28)
1,654 result(s) found for: Sex.
Displaying page 1 of 83.
EudraCT Number: 2005-003435-40 | Sponsor Protocol Number: CTU 0095 | Start Date*: 2006-08-29 | |||||||||||
Sponsor Name:Department of Health | |||||||||||||
Full Title: A Randomised Controlled Trial to Investigate the effectiveness of the Healthy Sexual Functioning (HSF) Module and Selective Serotonin Reuptake Inhibitor (SSRI) Medication to treat Deviant Sexual Ar... | |||||||||||||
Medical condition: Deviant Sexual Arousal (sex offender) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003072-31 | Sponsor Protocol Number: 2378 | Start Date*: 2018-05-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: The effects of sex hormone administration on marrow and visceral adiposity | ||
Medical condition: Healthy transgender persons (the effect of differences in sex hormones on the amount of bone marrow fat) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003666-13 | Sponsor Protocol Number: VAC89220HPX3002 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V. | |||||||||||||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1... | |||||||||||||
Medical condition: Prevention of HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000054-37 | Sponsor Protocol Number: ITM0514 | Start Date*: 2015-07-06 |
Sponsor Name:Institute of Tropical Medicine | ||
Full Title: Be-PrEP-ared: HIV prevention with Pre-exposure prophylaxis – a demonstration project in high risk men having sex with men in Belgium | ||
Medical condition: HIV prevention | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002327-13 | Sponsor Protocol Number: 2004VS002 | Start Date*: 2005-07-01 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: Mild to moderate intermittent claudication: the clinical and cost-effectiveness of supervised exercise programmes and Cilostazol therapy in patient management | ||
Medical condition: Intermittent claudication | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000502-19 | Sponsor Protocol Number: PSY-NIL-0002 | Start Date*: 2016-06-21 |
Sponsor Name:Medical University of Vienna, Department of Psychiatry and Psychotherapy | ||
Full Title: Effects of sex steroid hormones on serotonin synthesis and degradation measured with PET | ||
Medical condition: Gender Dysphoria (Female-to-male transsexuals and male-to-female transsexuals) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001881-14 | Sponsor Protocol Number: 20072650 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part 1 | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism caused by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001143-40 | Sponsor Protocol Number: OBEMO1EXT | Start Date*: 2016-06-22 |
Sponsor Name:Therapeutic Research Unit | ||
Full Title: Long-term effects of Roux-en-Y Gastric Bypass on morphine exposure after oral administration of immediate release morphine, in comparison with subjects without surgery | ||
Medical condition: Subjects volunteers who undergone Roux-en-Y gastric bypass (RYGB) for at least 48 months and control subjects matched for BMI, age and sex | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001238-21 | Sponsor Protocol Number: 2020-SESGEN | Start Date*: 2021-07-06 |
Sponsor Name:Institute of Health and Biomedical Research of Alicante | ||
Full Title: Gender biases in pain medicine: from omics to healthcare. | ||
Medical condition: The medical condition to be evaluated is the analgesic response of people with chronic low back pain who are going to be treated with opioids, guided by omics sciences (pharmacogenetics, epigeneti... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002084-20 | Sponsor Protocol Number: Version_1.0_MP_and_anticoagulants | Start Date*: 2011-07-28 |
Sponsor Name:Medizinische Universität Wien; Universitätsklinik für Klinische Pharmakologie | ||
Full Title: A prospective, randomized, controlled open-label trial to investigate the effects of 10mg rivaroxaban or 110mg dabigatran on microparticle formation in critically ill patients compared to age-& sex... | ||
Medical condition: The effect of the used IMPs should be investigated in critically ill patients and healthy subjects | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-004934-40 | Sponsor Protocol Number: 20072651 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part B | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism causes by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005613-38 | Sponsor Protocol Number: 44648368 | Start Date*: 2006-05-31 |
Sponsor Name:Dr. Chris Thompson | ||
Full Title: Assessment of platelet function in the hypopituitary population. Does hormone replacement therapy alter thrombotic risk? | ||
Medical condition: Hypopituitarism refers to decreased secretion of pituitary hormones, which can result from diseases of the pituitary gland or from diseases of the hypothalamus, which cause diminished secretion of ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002964-22 | Sponsor Protocol Number: AGO/2013/009 | Start Date*: 2013-12-10 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Influence of aromatase inhibitors on insulin sensitivity, liver and hart function in obese men | ||
Medical condition: Influence of aromatase inhibitors on insulin sensitivity, liver and hart function in obese men | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005607-13 | Sponsor Protocol Number: NN8640-4467 | Start Date*: 2022-07-15 | ||||||||||||||||||||||||||
Sponsor Name:NOVO NORDISK. S.P.A. | ||||||||||||||||||||||||||||
Full Title: A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with ... | ||||||||||||||||||||||||||||
Medical condition: Short stature born small for gestational age Turner syndrome Noonan syndrome Idiopathic short stature | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) SI (Ongoing) IE (Completed) DE (Ongoing) FI (Ongoing) GR (Ongoing) NL (Ongoing) BE (Ongoing) AT (Ongoing) ES (Ongoing) PT (Ongoing) BG (Ongoing) PL (Ongoing) LV (Ongoing) HR (Ongoing) LT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004984-11 | Sponsor Protocol Number: P150962J | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: "Study of maintenance of the efficacy and adverse effects of pharmacological treatments in sex offenders with paraphilia" ESPARA | |||||||||||||
Medical condition: Sexual offenders with paraphilia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000215-24 | Sponsor Protocol Number: GeSIDA10017 | Start Date*: 2018-06-05 |
Sponsor Name:Fundacion SEIMC-GESIDA | ||
Full Title: A single-arm, open-label and multicentre phase IV trial to evaluate the immunogenicity of the nonavalent vaccine against human papillomavirus in HIV-infected men who have sex with men. GESIDA 10017... | ||
Medical condition: AIDS | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002755-16 | Sponsor Protocol Number: 23 | Start Date*: 2007-11-07 |
Sponsor Name:University Hospital Heidelberg | ||
Full Title: Pharmakokinetik von Posaconazol verabreicht über Magensonde - POLICE-Studie (POsaconazoLe via gastrIC tubE) | ||
Medical condition: All subjects are patients of a SICU. Apache Score > 30. Infection treatment or prophylaxis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001972-36 | Sponsor Protocol Number: CSOM230C2305 | Start Date*: 2007-11-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomized, blinded study to assess the safety and efficacy of pasireotide LAR vs. octreotide LAR in patients with active acromegaly. | |||||||||||||
Medical condition: Acromegaly is characterized by chronic hypersecretion of growth hormone (GH), clinical features comprise structural and functional changes occurring in practically all organs. Cardiovascular diseas... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FR (Completed) BE (Completed) GB (Completed) GR (Completed) IT (Completed) ES (Completed) NL (Completed) DK (Completed) SE (Completed) HU (Completed) PL (Completed) PT (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016722-13 | Sponsor Protocol Number: CSOM230C2402 | Start Date*: 2010-06-10 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A phase III, multicenter, randomized, parallel-group study to assess the efficacy and safety of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open-label octreotide LAR or lanr... | |||||||||||||
Medical condition: Acromegaly is characterized by chronic hypersecretion of growth hormone (GH), clinical features comprise structural and functional changes occurring in practically all organs. Cardiovascular diseas... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) ES (Completed) IT (Completed) NO (Completed) BE (Completed) DE (Completed) PL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005078-37 | Sponsor Protocol Number: SOPHOCLES-P4G | Start Date*: 2017-05-26 | |||||||||||
Sponsor Name:Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases | |||||||||||||
Full Title: Public health targeting of PrEP at HIV positives’ bridging networks | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.